首页> 外文学位 >Novel vascular grafts based on polyphenol-stabilized acellular tissue scaffolds.
【24h】

Novel vascular grafts based on polyphenol-stabilized acellular tissue scaffolds.

机译:基于多酚稳定的脱细胞组织支架的新型血管移植物。

获取原文
获取原文并翻译 | 示例

摘要

The Cardiovascular diseases (CVDs) continue to be the leading cause of morbidity and mortality worldwide. The most common form of CVDs is occlusion of blood flow thus limiting blood supply to specific tissues or organs. Atherosclerosis is a leading cause of coronary heart disease and stroke, which were responsible for more than 25% of deaths in 2004.;The demand for vascular graft is huge. In United States alone, approximately 500,000 coronary artery bypass graft surgeries are performed annually. Synthetic polymers such as Dacron and ePTFE have been successfully applied in large diameter blood vessel prosthesis; however, for small diameter (inner diameter 6mm) blood vessel replacement, both performed poorly in small diameter indications. Autologous saphenous vein or internal mammary artery remains the gold standard. However, autologous vessel is not available in about 1/3 of the patients.;We proposed a novel biological scaffold based on decellularization of porcine arteries. Decellularized arterial scaffolds were further stabilized with penta-galloyl glucose (PGG) to render it more resistant to rapid in vivo biodegradation. The resultant scaffolds had good mechanical properties in burst pressure and vascular compliance. Subdermal implantation study showed that our novel scaffolds were biocompatible, inductive to host cell repopulation and had good remodeling potential.;A dynamic cell seeding device which is capable of utilizing three different mechanisms was designed and built to endothelialize luminal surface of grafts. Of three mechanisms, electrical field and hydrostatic pressure seeding methods resulted in overall good cell coverage, while chemotaxis was the least efficient.;We further developed a pulsatile vascular bioreactor to test endothelial cells retention under pulsatile flow. Grafts expanded and recoiled in response to the pulsatile flow created by the pinch valve periodically opening/closing at 1Hz. We found that seeded endothelial cells could withstand to 20h of pulsation and stayed alive, as shown in the DiffQuik and Live/Dead staining results.;In collaboration with researchers in Japan & South Africa, we tested the functionality of our PGG-stabilized scaffolds using animal circulation models. Vascular graft of about 5 cm long was anastomosed to host artery in end-to-end fashion. Preliminary data showed that our novel acellular vascular scaffolds were very inductive to host cell repopulation. Heparinized grafts remained patent after 7 days.
机译:心血管疾病(CVD)仍然是全世界发病率和死亡率的主要原因。 CVD的最常见形式是阻塞血流,从而限制了向特定组织或器官的血液供应。动脉粥样硬化是导致冠心病和中风的主要原因,在2004年,动脉粥样硬化占死亡的25%以上。对血管移植物的需求巨大。仅在美国,每年就进行约500,000例冠状动脉搭桥手术。合成聚合物(如Dacron和ePTFE)已成功应用于大直径血管假体中。但是,对于小直径(内径<6mm)的血管更换,在小直径适应症中均表现不佳。自体隐静脉或乳内动脉仍然是金标准。然而,约有1/3的患者无法使用自体血管。;我们提出了一种基于猪动脉脱细胞的新型生物支架。去细胞的动脉支架进一步用五没食子酰基葡萄糖(PGG)稳定化,使其对体内快速生物降解更具抵抗力。所得支架在破裂压力和血管顺应性方面具有良好的机械性能。皮下植入研究表明,我们的新型支架具有生物相容性,可诱导宿主细胞重塑并具有良好的重塑潜力。设计并构建了一种能够利用三种不同机制的动态细胞播种装置,以使移植物的腔表面内皮化。在三种机制中,电场和静水压力播种方法导致总体上良好的细胞覆盖率,而趋化性效率最低。;我们进一步开发了一种搏动性血管生物反应器,以测试脉动流下内皮细胞的保留。响应于由夹管阀以1Hz定期打开/关闭所产生的脉动流,移植物会膨胀和反冲。如DiffQuik和活/死染色结果所示,我们发现播种的内皮细胞可以承受20h的搏动并保持存活;;与日本和南非的研究人员合作,我们使用以下方法测试了PGG稳定的支架的功能:动物循环模型。将约5 cm长的血管移植物端对端地吻合到宿主动脉。初步数据表明,我们新型的脱细胞血管支架对宿主细胞的繁殖非常有诱导作用。肝素化移植物在7天后仍保持专利。

著录项

  • 作者

    Chuang, Ting-Hsien.;

  • 作者单位

    Clemson University.;

  • 授予单位 Clemson University.;
  • 学科 Engineering Biomedical.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 137 p.
  • 总页数 137
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号